SCHEMBL30867279

SCHEMBL30867279

CCOC(=O)c1c(N)nc(C(F)(F)F)c(Cl)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
LMNA P02545 1/20 0.50
PKM P14618 1/20 0.50
IDO1 P14902 1/20 0.44
RAB9A P51151 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TP53 P04637 1/20 0.41
ALDH1A1 P00352 8/20 0.41
HPGD P15428 6/20 0.41
MAPT P10636 5/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 1/20 0.41
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30867287 0.84 KDM4E (0.43) KDM4ELMNAPKMIDO1ALDH1A1
SCHEMBL10373408 0.79 KDM4E (0.48) KDM4ELMNAPKMIDO1RAB9A
SCHEMBL6733600 0.78 KDM4E (0.45) KDM4ELMNAPKMIDO1ALDH1A1
SCHEMBL14783264 0.77 KDM4E (0.50) KDM4ELMNAPKMIDO1HSD17B10
SCHEMBL14967259 0.77 KDM4E (0.47) KDM4ELMNAPKMIDO1RAB9A
SCHEMBL2371687 0.76 KDM4E (0.55) KDM4ELMNAPKMIDO1RAB9A
SCHEMBL10370830 0.76 KDM4E (0.55) KDM4ELMNAPKMIDO1RAB9A
SCHEMBL9726366 0.76 KDM4E (0.50) KDM4ELMNAPKMIDO1RAB9A
SCHEMBL14966711 0.75 KDM4E (0.50) KDM4ELMNAPKMIDO1RAB9A
SCHEMBL10373414 0.74 KDM4E (0.44) KDM4ELMNAPKMIDO1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583867-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2025-07-16 EP disclosed
WO-2024054622-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2024-03-14 WO disclosed